# Natural Resource Partners LP: financial statements, quarterly

NRP · NYSE · CIK 1171486 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nrp.md) · [Financials](/companies/nrp/financials.md) · [Filings](/companies/nrp/filings.md) · [Insiders](/companies/nrp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nrp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [68.5](/filings/0001437749-24-033247.md) | [72.9 d](/filings/0001437749-25-005715.md) | [65.6](/filings/0001437749-25-014693.md) | [54.6](/filings/0001437749-24-025065.md) | [50.4](/filings/0001437749-24-033247.md) | [61.8 d](/filings/0001437749-25-005715.md) | [51.3](/filings/0001437749-25-014693.md) | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [67.7](/filings/0001437749-24-033247.md) | [68.9 d](/filings/0001437749-26-006147.md) | [59.7](/filings/0001437749-25-014693.md) | [50.4](/filings/0001437749-25-024999.md) | [42.8](/filings/0001437749-25-032941.md) | [46.3 d](/filings/0001437749-26-006147.md) | [42.9](/filings/0001437749-26-015150.md) | [36.6](/filings/0001437749-26-025856.md) | [32.7](/filings/0001437749-25-032941.md) | [32.2 d](/filings/0001437749-26-006147.md) | [20.6](/filings/0001437749-26-015150.md) | [26.2](/filings/0001437749-26-025856.md) |
| Interest expense | $m | [3.8](/filings/0001437749-23-030163.md) | [3.9 d](/filings/0001437749-24-007008.md) | [3.5](/filings/0001437749-24-014986.md) | [4.3](/filings/0001437749-25-024999.md) | [4.2](/filings/0001437749-25-032941.md) | [3.5 d](/filings/0001437749-26-006147.md) | [2.7](/filings/0001437749-26-015150.md) | [2.4](/filings/0001437749-26-025856.md) | [1.8](/filings/0001437749-25-032941.md) | [1.2 d](/filings/0001437749-26-006147.md) | [1.0](/filings/0001437749-26-015150.md) | [1.1](/filings/0001437749-26-025856.md) |
| Net income | $m | [63.8](/filings/0001437749-24-033247.md) | [65.0 d](/filings/0001437749-26-006147.md) | [56.2](/filings/0001437749-25-032941.md) | [46.1](/filings/0001437749-25-032941.md) | [38.6](/filings/0001437749-25-032941.md) | [42.8 d](/filings/0001437749-26-006147.md) | [40.3](/filings/0001437749-26-025856.md) | [34.2](/filings/0001437749-26-025856.md) | [30.9](/filings/0001437749-25-032941.md) | [31.0 d](/filings/0001437749-26-006147.md) | [19.6](/filings/0001437749-26-025856.md) | [25.2](/filings/0001437749-26-025856.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:ProfitLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.4](/filings/0001437749-23-030163.md) | [12.0](/filings/0001437749-25-005715.md) | [11.0](/filings/0001437749-24-014986.md) | [32.3](/filings/0001437749-24-025065.md) | [30.9](/filings/0001437749-24-033247.md) | [30.4](/filings/0001437749-26-006147.md) | [30.9](/filings/0001437749-25-014693.md) | [30.3](/filings/0001437749-25-024999.md) | [31.0](/filings/0001437749-25-032941.md) | [30.1](/filings/0001437749-26-025856.md) | [31.5](/filings/0001437749-26-015150.md) | [30.1](/filings/0001437749-26-025856.md) |
| Current assets | $m | [59.6](/filings/0001437749-23-030163.md) | [55.3](/filings/0001437749-25-005715.md) | [48.4](/filings/0001437749-24-014986.md) | [66.1](/filings/0001437749-24-025065.md) | [69.3](/filings/0001437749-24-033247.md) | [63.9](/filings/0001437749-26-006147.md) | [64.4](/filings/0001437749-25-014693.md) | [60.7](/filings/0001437749-25-024999.md) | [61.9](/filings/0001437749-25-032941.md) | [60.9](/filings/0001437749-26-025856.md) | [59.7](/filings/0001437749-26-015150.md) | [61.7](/filings/0001437749-26-025856.md) |
| Total assets | $m | [815](/filings/0001437749-23-030163.md) | [798](/filings/0001437749-25-005715.md) | [773](/filings/0001437749-25-014693.md) | [790](/filings/0001437749-24-025065.md) | [773](/filings/0001437749-25-032941.md) | [773](/filings/0001437749-26-006147.md) | [748](/filings/0001437749-26-015150.md) | [748](/filings/0001437749-26-025856.md) | [754](/filings/0001437749-25-032941.md) | [748](/filings/0001437749-26-025856.md) | [772](/filings/0001437749-26-015150.md) | [758](/filings/0001437749-26-025856.md) |
| Current liabilities | $m | [52.1](/filings/0001437749-23-030163.md) | [49.8](/filings/0001437749-25-005715.md) | [27.4](/filings/0001437749-24-014986.md) | [27.1](/filings/0001437749-24-025065.md) | [29.7](/filings/0001437749-24-033247.md) | [31.9](/filings/0001437749-26-006147.md) | [26.3](/filings/0001437749-25-014693.md) | [27.6](/filings/0001437749-25-024999.md) | [28.9](/filings/0001437749-25-032941.md) | [33.0](/filings/0001437749-26-025856.md) | [28.6](/filings/0001437749-26-015150.md) | [29.2](/filings/0001437749-26-025856.md) |
| Total liabilities | $m | [265](/filings/0001437749-23-030163.md) | [220](/filings/0001437749-25-005715.md) | [247](/filings/0001437749-24-014986.md) | [270](/filings/0001437749-24-025065.md) | [273](/filings/0001437749-24-033247.md) | [222](/filings/0001437749-26-006147.md) | [208](/filings/0001437749-25-014693.md) | [172](/filings/0001437749-25-024999.md) | [142](/filings/0001437749-25-032941.md) | [116](/filings/0001437749-26-025856.md) | [139](/filings/0001437749-26-015150.md) | [107](/filings/0001437749-26-025856.md) |
| Long-term debt | $m | [171](/filings/0001437749-23-030163.md) | [124](/filings/0001437749-25-005715.md) | [175](/filings/0001437749-24-014986.md) | [196](/filings/0001437749-24-025065.md) | [183](/filings/0001437749-24-033247.md) | [128](/filings/0001437749-26-006147.md) | [125](/filings/0001437749-25-014693.md) | [87.1](/filings/0001437749-25-024999.md) | [55.1](/filings/0001437749-25-032941.md) | [18.9](/filings/0001437749-26-025856.md) | [46.1](/filings/0001437749-26-015150.md) | [13.1](/filings/0001437749-26-025856.md) |
| Current portion of debt | $m | [36.8](/filings/0001437749-23-030163.md) | [30.8](/filings/0001437749-25-005715.md) | [14.2](/filings/0001437749-24-014986.md) | [14.2](/filings/0001437749-24-025065.md) | [14.2](/filings/0001437749-24-033247.md) | [14.2](/filings/0001437749-26-006147.md) | [14.2](/filings/0001437749-25-014693.md) | [14.2](/filings/0001437749-25-024999.md) | [14.2](/filings/0001437749-25-032941.md) | [14.2](/filings/0001437749-26-025856.md) | [14.2](/filings/0001437749-26-015150.md) | [14.3](/filings/0001437749-26-025856.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [78.9 d](/filings/0001437749-24-033247.md) | [77.8 d](/filings/0001437749-26-006147.md) | [71.5](/filings/0001437749-25-014693.md) | [56.6 d](/filings/0001437749-25-024999.md) | [54.1 d](/filings/0001437749-25-032941.md) | [66.2 d](/filings/0001437749-26-006147.md) | [34.4](/filings/0001437749-26-015150.md) | [45.6 d](/filings/0001437749-26-025856.md) | [41.1 d](/filings/0001437749-25-032941.md) | [44.8 d](/filings/0001437749-26-006147.md) | [33.0](/filings/0001437749-26-015150.md) | [41.0 d](/filings/0001437749-26-025856.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001437749-24-033247.md) | [0.0 d](/filings/0001437749-26-006147.md) | [0.0](/filings/0001437749-24-014986.md) | [0.0 d](/filings/0001437749-24-025065.md) | [0.0 d](/filings/0001437749-24-033247.md) | [0.0 d](/filings/0001437749-26-006147.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Shares outstanding: 13,250,412 at 2026-08-05, from the cover of the [10-Q filed 2026-08-05](/filings/0001437749-26-025856.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.